101 related articles for article (PubMed ID: 16917732)
1. Bounds on the covariate-time transformation for competing-risks survival analysis.
Bond SJ; Shaw JE
Lifetime Data Anal; 2006 Sep; 12(3):285-303. PubMed ID: 16917732
[TBL] [Abstract][Full Text] [Related]
2. Identifiability assumptions for missing covariate data in failure time regression models.
Rathouz PJ
Biostatistics; 2007 Apr; 8(2):345-56. PubMed ID: 16840561
[TBL] [Abstract][Full Text] [Related]
3. On assessing independence of competing risks when failure times are discrete.
Crowder M
Lifetime Data Anal; 1996; 2(2):195-209. PubMed ID: 9384644
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent covariates in the proportional subdistribution hazards model for competing risks.
Beyersmann J; Schumacher M
Biostatistics; 2008 Oct; 9(4):765-76. PubMed ID: 18434297
[TBL] [Abstract][Full Text] [Related]
5. Fitting competing risks with an assumed copula.
Escarela G; Carrière JF
Stat Methods Med Res; 2003 Aug; 12(4):333-49. PubMed ID: 12939100
[TBL] [Abstract][Full Text] [Related]
6. Competing risks and time-dependent covariates.
Cortese G; Andersen PK
Biom J; 2010 Feb; 52(1):138-58. PubMed ID: 20029852
[TBL] [Abstract][Full Text] [Related]
7. Joint modeling of repeated multivariate cognitive measures and competing risks of dementia and death: a latent process and latent class approach.
Proust-Lima C; Dartigues JF; Jacqmin-Gadda H
Stat Med; 2016 Feb; 35(3):382-98. PubMed ID: 26376900
[TBL] [Abstract][Full Text] [Related]
8. Large sample bounds on the survivor average causal effect in the presence of a binary covariate with conditionally ignorable treatment assignment.
Freiman MH; Small DS
Int J Biostat; 2014; 10(2):143-63. PubMed ID: 25294716
[TBL] [Abstract][Full Text] [Related]
9. Assessing time-by-covariate interactions in relative survival models using restrictive cubic spline functions.
Bolard P; Quantin C; Abrahamowicz M; Esteve J; Giorgi R; Chadha-Boreham H; Binquet C; Faivre J
J Cancer Epidemiol Prev; 2002; 7(3):113-22. PubMed ID: 12665210
[TBL] [Abstract][Full Text] [Related]
10. Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach.
Faucett CL; Thomas DC
Stat Med; 1996 Aug; 15(15):1663-85. PubMed ID: 8858789
[TBL] [Abstract][Full Text] [Related]
11. Estimates of clinically useful measures in competing risks survival analysis.
Ambrogi F; Biganzoli E; Boracchi P
Stat Med; 2008 Dec; 27(30):6407-25. PubMed ID: 18937229
[TBL] [Abstract][Full Text] [Related]
12. An approach to joint analysis of longitudinal measurements and competing risks failure time data.
Elashoff RM; Li G; Li N
Stat Med; 2007 Jun; 26(14):2813-35. PubMed ID: 17124698
[TBL] [Abstract][Full Text] [Related]
13. Bounds for a joint distribution function with fixed sub-distribution functions: Application to competing risks.
Peterson AV
Proc Natl Acad Sci U S A; 1976 Jan; 73(1):11-3. PubMed ID: 16592299
[TBL] [Abstract][Full Text] [Related]
14. A representation of mortality data by competing risks.
Hoel DG
Biometrics; 1972 Jun; 28(2):475-88. PubMed ID: 4556703
[No Abstract] [Full Text] [Related]
15. Evaluating constraints that allow survival-adjusted incidence analyses in single-sacrifice studies.
Dinse GE
Biometrics; 1993 Jun; 49(2):399-407. PubMed ID: 8369376
[TBL] [Abstract][Full Text] [Related]
16. Regression modeling of semicompeting risks data.
Peng L; Fine JP
Biometrics; 2007 Mar; 63(1):96-108. PubMed ID: 17447934
[TBL] [Abstract][Full Text] [Related]
17. Introduction to the Analysis of Survival Data in the Presence of Competing Risks.
Austin PC; Lee DS; Fine JP
Circulation; 2016 Feb; 133(6):601-9. PubMed ID: 26858290
[TBL] [Abstract][Full Text] [Related]
18. Pre-transplant (18)F-fluorodeoxyglucose positron emission tomography-based survival model in patients with aggressive lymphoma undergoing high-dose chemotherapy and autologous SCT.
Akhtar S; Al-Sugair AS; Abouzied M; Alkadhi Y; Dingle M; Abdelsalam M; Soudy H; Darwish A; Eltigani A; Elhassan TA; Nabil-Ahmed M; Maghfoor I
Bone Marrow Transplant; 2013 Apr; 48(4):551-6. PubMed ID: 22964592
[TBL] [Abstract][Full Text] [Related]
19. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
Rodriguez R; Nademanee A; Ruel N; Smith E; Krishnan A; Popplewell L; Zain J; Patane K; Kogut N; Nakamura R; Sarkodee-Adoo C; Forman SJ
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1326-34. PubMed ID: 17162215
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the marginal hazard model and the sub-distribution hazard model for competing risks under an assumed copula.
Emura T; Shih JH; Ha ID; Wilke RA
Stat Methods Med Res; 2020 Aug; 29(8):2307-2327. PubMed ID: 31868107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
